Fine specificity of Plasmodium vivax duffy binding protein binding engagement of the duffy antigen on human erythrocytes

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2920-2928

  Siddiqui, Asim A ^a   Xainli, Jia ^a   Schloegel, Jesse ^b   Carias, Lenore ^a   Ntumngia, Francis ^b   Shoham, Menachem ^a   Casey, Joanne L ^c   Foley, Michael ^c   Adams, John H ^b   King, Christopher L ^a,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c LA TROBE UNIVERSITY   (Australia)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DUFFY ANTIGEN; DUFFY BINDING PROTEIN; MONOCLONAL ANTIBODY; PROTEIN SUBDOMAIN 1; PROTEIN SUBDOMAIN 2; PROTEIN SUBDOMAIN 3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BINDING SITES; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; GENE EXPRESSION REGULATION; HUMANS; MODELS, MOLECULAR; PLASMODIUM VIVAX; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RATS; RECEPTORS, CELL SURFACE;

EID: 84864797567     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00206-12     Document Type: Article

References (41)

1. Adams JH, Blair PL, Kaneko O, Peterson DS. 2001. An expanding ebl family of Plasmodium falciparum. Trends Parasitol. 17: 297-299.
2. Adams JH, et al. 1992. A family of erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. U. S. A. 89: 7085-7089.
3. Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA. 1996. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol. Biochem. Parasitol. 78: 269 -272.
4. Barnwell JW, Nichols ME, Rubinstein P. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 169: 1795-1802.
5. Batchelor JD, Zahm JA, Tolia NH. 2011. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat. Struct. Mol. Biol. 18: 908 -914.
6. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH. 1996. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med. 184: 1531- 1536.
7. Chitnis CE, Miller LH. 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 180: 497-506.
8. Choe H, et al. 2005. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/ receptor for chemokines (DARC). Mol. Microbiol. 55: 1413-1422.
9. Chootong P, et al. 2010. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect. Immun. 78: 1089 -1095.
10. Cole-Tobian J, King CL. 2003. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol. Biochem. Parasitol. 127: 121-132.
11. Cole-Tobian JL, et al. 2002. Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein. J. Infect. Dis. 186: 531- 539.
12. Cole-Tobian JL, Michon P, Dabod E, Mueller I, King CL. 2007. Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children. Am. J. Trop. Med. Hyg. 77: 955-962.
13. Cole-Tobian JL, Zimmerman PA, King CL. 2007. High-throughput identification of the predominant malaria parasite clone in complex blood stage infections using a multi-SNP molecular haplotyping assay. Am. J. Trop. Med. Hyg. 76: 12-19.
14. Coley AM, et al. 2006. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasioninhibitory antibody. Infect. Immun. 74: 2628 -2636.
15. Genton B, et al. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 185: 820-827.
16. Grimberg BT, et al. 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 4: e337. doi: 10.1371/journal.pmed.0040337.
17. Hans D, et al. 2005. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol. Microbiol. 55: 1423-1434.
18. Haynes JD, et al. 1988. Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J. Exp. Med. 167: 1873-1881.
19. Howell DP, et al. 2008. Mapping a common interaction site used by Plasmodium falciparum Duffy binding-like domains to bind diverse host receptors. Mol. Microbiol. 67: 78-87.
20. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47(Pt 2): 110 -119.
21. King CL, et al. 2011. Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U. S. A. 108: 20113-20118.
22. King CL, et al. 2008. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. U. S. A. 105: 8363- 8368.
23. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295: 302-304.
24. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. 1975. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189: 561-563.
25. Ntumngia FB, Adams JH. 2012. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax Duffy binding protein. Clin. Vaccine Immunol. 19: 30 -36.
26. Ntumngia FB, et al. 2012. Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies. Infect. Immun. 80: 1203-1208.
27. Ouattara A, et al. 2010. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar J. 9: 175. doi: 10.1186/1475-2875-9-175.
28. Ranjan A, Chitnis CE. 1999. Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 96: 14067-14072.
29. Russell B, et al. 2011. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood 118: e74-e81. doi: 10.1182/blood-2011-04-348748.
30. Singh AP, Puri SK, Chitnis CE. 2002. Antibodies raised against receptorbinding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. Mol. Biochem. Parasitol. 121: 21-31.
31. Singh K, et al. 2010. Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x is identified as a minimal chondroitin sulfate A-binding region. J. Biol. Chem. 285: 24855-24862.
32. Singh K, et al. 2008. Structure of the DBL3x domain of pregnancyassociated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat. Struct. Mol. Biol. 15: 932-938.
33. Singh S, et al. 2001. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein. J. Biol. Chem. 276: 17111- 17116.
34. Singh SK, Hora R, Belrhali H, Chitnis CE, Sharma A. 2006. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439: 741-744.
35. Tran TM, et al. 2005. Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. Cytometry A 63: 59-66.
36. Tsuboi T, et al. 1994. Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding protein. Infect. Immun. 62: 5581-5586.
37. VanBuskirk KM, Sevova E, Adams JH. 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. U. S. A. 101: 15754-15759.
38. Walsh C. 2006. Posttranslational modification of proteins: expanding nature's inventory. Roberts and Co. Publishers, Englewood, CO.
39. Wertheimer SP, Barnwell JW. 1989. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp. Parasitol. 69: 340 -350.
40. Xainli J, Adams JH, King CL. 2000. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol. Biochem. Parasitol. 111: 253-260.
41. Xainli J, et al. 2002. Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J. Immunol. 169: 3200- 3207.